Promoter methylation status of PTEN, SYK and survivin genes in breast cancer tissues derived from Chinese women

Asian Biomedicine

Volumn 3, Issue 6, 2009, Pages 595-601

  Lu, Xiaowei ^a   Gu, Yumei ^b   Zhu, Dongliang ^b   Tan, Jianxin ^b   Liu, Xiaorong ^b   Zha, Xiaoming ^b  

^a Department of Breast Surgery   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Methylation status; PTEN; Survivin; SYK

Indexed keywords

PARAFFIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE SYK; SURVIVIN;

ARTICLE; BREAST CANCER; CANCER TISSUE; CHINESE; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; FEMALE; GENE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RANDOM SAMPLE; SEQUENCE ANALYSIS;

EID: 79952136842     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol. 1999;155:1254-60.
2. Di Cristofano AD, and Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell. 2000;100:387-90.
3. Garcia JM, Silva J, Pena C, Garcia V, Rodriguez R, Cruz MA, et al. Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer. 2004;41:117-24. (Pubitemid 39096737)
4. Zysman MA, Chapman WB, Bapat B. Considerations when analyzing the methylation status of PTEN tumor suppressor gene. Am J Pathol. 2002;160:795-800. (Pubitemid 34224569)
5. Yuan Y, Mendez R, Sahin A, Dai JL. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res. 2001;61:5558-61. (Pubitemid 32694942)
6. Yuan Y, Liu H, Sahin A, Dai JL. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness. Int J Cancer. 2005;113:654-9. (Pubitemid 40038744)
7. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6:127-34. (Pubitemid 30064984)
8. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancers. Cancer Res. 1998;85:5071-4. (Pubitemid 28521163)
9. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med. 1999;341:452-3. (Pubitemid 29362524)
10. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res. 2003;82:607-11. (Pubitemid 41766142)
11. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA Extraction from archival formalin-fixed, paraffinembedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002;50:1005-11. (Pubitemid 34827622)
12. Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation Clin Cancer Res. 2002;8:1178-84.
13. Yu J, Zhang H, Gu J, Lin S, Li J, Lu W, et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer. 2004;4:65.
14. Lloyd KM, Dennis M. Cowden's disease: a possible new symptom complex with multiple system involvement. Ann Inter Med. 1963;58:136-42.
15. Mallory SB. Cowden syndrome (multiple hamartoma syndrome). Dermatol Clin. 1995;13:27-31.
16. Rhei E, Kang L, Bogomolinly F, Federici MG, Borgen PI, Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 1997;57:3657-9. (Pubitemid 27381202)
17. Steck PA, Perhouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Identification of a candidate tumour suppressor gene, MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15:356-62. (Pubitemid 27147102)
18. Stingh B, Ittmann MM, Krolewski JJ. Sporadic breast cancer exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden Disease locus. Genes Chromosomes Cancer. 1998;21:166-71. (Pubitemid 28081244)
19. Garca JM, Silva JM, Dominguez G, Gonzalez R, Navarro A, Carretero L, et al. Allelic loss of PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Tr. 1999;57:237-43.
20. Dahia PL, FitzGerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, et al. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene. 1998;16:2403-6. (Pubitemid 28226888)
21. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol. 2004;10:3441-54. (Pubitemid 39549544)
22. Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer. 2002;2:29.
23. Khan S, Kumagai T, Vora J, Bose N, Sehgal I, Koeffler PH, et al. PTEN promoter is methylated in a proportion of invasive breast cancers. Int J Cancer. 2004;112:407-10. (Pubitemid 39390604)
24. Wei JJ, Chiriboga L, Arslan AA, Melamed J, Yee H, Mittal K. Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod. 2006;21:57-67. (Pubitemid 41794292)
25. Joe AK, Arber N, Bose S, Heitjan D, Zhang Y, Weinstein IB, et al. Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer. Anticancer Res. 2001;21:3535-9. (Pubitemid 34224262)
26. Gu YM, Tan JX, Lu XW, Ding Y, Han X, Sun YJ. BCSG1 Methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer. Oncology. 2008;74:61-8. (Pubitemid 351915011)
27. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998;7:507-15. (Pubitemid 28120643)
28. Bose S, Wang SI, Terry MB, Hibshoosh H, Parsons R. Allelic loss of chromosome 10q23 is associated with invasion in breast carcinomas. Oncogene. 1998;17:123-7. (Pubitemid 28360536)
29. Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, et al. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res. 2003;63:4724-30. (Pubitemid 36951053)